Acne News

 
 
  • Evidence on Spironolactone Safety in COVID-19 Reassuring Spironolactone and other androgen blockers might actually protect against the virus, according to a report in the Journal of the American Academy of Dermatology.
  • A Step-by-Step Guide to Preventing PPE-Related Skin Damage The PPE worn during COVID-19 is a double-edged sword — it helps fight transmission of the virus, but can also harm the skin of the healthcare providers who must wear it for prolonged periods of time.
  • Alert EU Restricts High-Dose Cyproterone Because of Meningioma Risk Products containing the antiandrogen cyproterone with daily doses of 10 mg or more should be restricted because of a risk of meningioma.
  • Racial Differences Seen in Acne Treatment for U.S. Patients Black patients may be less likely than whites to receive aggressive treatment for acne, a new study suggests.
  • Alert FDA OKs First Tazarotene Lotion (Arazlo) for Acne Vulgaris Arazlo is the first tazarotene acne treatment available in lotion form, and has been shown to provide strong efficacy with favorable tolerability, the company said.
  • Drug Extends Overall Survival in Some Lung Cancer Patients by 20% Final results of AstraZeneca's FLAURA trial show a 20% increase in median overall survival among patients given osimertinib for untreated, advanced non-small-cell lung cancer with an epidermal growth factor receptor mutation, compared to patients who receive gefitinib or erlotinib.
  • Dermatologists Urged to Combat Medical Overuse Dermatologists can reduce medical overuse and mitigate patient morbidity from unnecessary interventions through evidence-based practices, a systematic review reveals.
  • Travel Medicine Planning Often Skips Contraception When women visit travel medicine clinics before a trip, analysis of their pre-journey health needs often doesn't cover contraception options and availability, a new paper warns.
  • Alert FDA Clears First Topical Form of Minocycline for Acne Minocycline topical foam (Amzeeq) is for the treatment of inflammatory lesions of nonnodular moderate to severe acne vulgaris in adults and children aged 9 years or older.
  • FDA OKs Trifarotene, First New Retinoid Acne Cream in 20 Years Trifarotene cream 0.005% (Aklief), approved for patients aged 9 years or older, is the first topical treatment specifically studied and proven to treat acne vulgaris on both the face and trunk.
  • Oral Contraceptives Tied to Psychiatric Symptoms in Teens Use of oral contraceptives is associated with an increased risk for depressive and other psychiatric symptoms in teenage girls, new research shows.
  • A 'Unicorn' Pushes for Diversity in Dermatology Years-long efforts to diversify dermatology, one of the least diverse medical specialties, are gaining momentum.
  • Some Women Don't Heed Warnings of Acne Drug Danger During Pregnancy Conception It's long been known that the highly effective acne medication isotretinoin is tied to the risk of severe birth defects. But even with a special program in place to prevent conception in women taking the drug, each year 200 to 300 women in the U.S. become pregnant while taking it, a new study shows.
  • Psychiatric Adverse Events Common With Isotretinoin People taking isotretinoin for severe acne commonly experience psychiatric adverse events, according to data from the U.S. Food and Drug Administration's Adverse Event Reporting System (FAERS) and the iPLEDGE program.
  • Mail-Order Medicine: Prescribe With Caution A California physician surrendered his license after prescribing drugs with only the patient information from an online questionnaire, and there are still 'unanswered questions' about regulation.
  • Trimethoprim-Sulfamethoxazole Linked to ARDS Severe acute respiratory distress syndrome has been linked to trimethoprim-sulfamethoxazole treatment in previously healthy teenagers in a recent case series.
  • ENDO 2019Osilodrostat Continues to Show Promise for Cushing's Disease The investigational 11β-hydroxylase normalized mean urinary free cortisol in most patients and was well-tolerated.
  • AAD 2019Acne Inversa Linked to Cardiovascular Disease People with inflamed and swollen skin lesions are at elevated risk for cardiovascular events, even at a young age, so should be monitored closely, dermatologists advise.
  • Behind the Pimple Video Craze Millions of viewers around the world visit the website YouTube to watch people pop pimples. Some pimple poppers have even become stars of sorts. The reasons behind the phenomenon are varied.
  • Alert FDA Approves Sarecycline for Moderate to Severe Acne The FDA has approved sarecycline (Seysara, Almirall) for patients aged 9 years and older with inflammatory lesions associated with non-nodular moderate to severe acne vulgaris.